Implementation Specialist

Suvoda earns two PM360 Innovation Awards for Sofia AI assistant and Suvoda App. September 16, 2026 at 13:30 PM EDT i This article is third-party content and does not represent the views of this site. Tamar Securities, LLC make no guarantees regarding its accuracy or completeness. CONSHOHOCKEN, Pa., Sept. 16, 2026 (GLOBE NEWSWIRE) - Suvoda, a global clinical trial technology company, today announced that PM360 has named the company a winner of two 2026 Innovation Awards: Sofia, Suvoda's AI assistant, in the Artificial Intelligence category, and the Suvoda App in the Clinical Trials category. Both innovations will be featured in PM360's September issue. For Suvoda, the recognition acknowledges its focus on reducing the burdens that people encounter at different points in a clinical trial: patients managing visits, questionnaires, travel, and reimbursement alongside the demands of daily life; site teams tracking study status, drug supplies, and participant needs; and sponsors coordinating complex studies where delays and disconnected information can slow decisions. Suvoda built Sofia and the Suvoda App to address those burdens. Sofia: a conversational AI assistant built for regulated trials Sofia gives study teams faster access to the RTSM study data and eCOA information they need to understand what is happening in a trial and take the next step. Through a conversational interface, sponsors can chat with Sofia to gain insights into drug inventory, access reports, and understand the latest trial status, helping them make confident decisions. Sites can get fast answers to common questions about their trial, so they can spend less time navigating the system and more time advancing the trial. Sofia provides clear, contextual answers, accompanied by relevant tables and visualizations. Suvoda built Sofia with guardrails designed to constrain responses to tested, study-specific information while keeping answers auditable and enforcing role-based access and data privacy controls. For example, Sofia applies each user's role, permissions, and study context while maintaining study blinding and data integrity. Sofia can respond to questions across more than 40 topics, with deterministic instructions and fully validated responses. It runs on the Suvoda Platform, which has supported more than 6,000 trials across more than 115 countries. "Clinical trial teams need fast, clear answers to the questions that come up every day," said Jadon Sargeant, Senior Product Owner at Suvoda. "With Sofia, we're putting that information closer to the moment a decision needs to be made. This recognition reflects the care we've taken to make AI useful in a highly regulated industry, staying grounded in study context, permissions, and thorough testing." Suvoda App: one place for the patients' study needs The Suvoda App gives patients more control over their clinical trial experience by bringing several tasks into one mobile experience. Instead of navigating separate tools, emails, and phone calls, patients can complete questionnaires and diaries, submit receipts, track reimbursement status, book a rideshare, view travel details, schedule and reschedule visits, and receive important reminders in one place. "Participating in a clinical trial is already a lot to ask of someone," said Elizabeth Smith, Director of Product Management, Patient Engagement at Suvoda. "The Suvoda App brings together many activities which have historically been separate and confusing. Now patients can see what they need to do next and take care of everything in one place. This award reflects that we listened when patients and sites told us how their experiences could be simpler." Together, Sofia and the Suvoda App reflect Suvoda's ambition to build technology that eases the experience for the people doing the hard, essential work in clinical trials, so that life-changing studies can keep moving forward. For the past 13 years, PM360's Innovation Issue has highlighted advancements across life sciences and healthcare. PM360 describes itself as the premier magazine for marketing decision makers in the pharmaceutical, biotech, and medical device industries. Innovation Award submissions are judged by PM360's editorial department, with selected innovations featured in the publication's Innovation Issue. About Suvoda Suvoda is a global clinical trial technology company with a market-leading, real-time software platform that empowers sponsors and CROs to make confident decisions and sites and patients to take calm, controlled action. Suvoda delivers interconnected, action-driven software solutions and industry-leading services and support, so that even in the most time-sensitive, mission-critical moments, life-changing studies keep moving forward. Headquartered outside Philadelphia, Suvoda also maintains offices in Portland, OR, Barcelona, Spain, Bucharest and Iasi, Romania, and Tokyo, Japan. The company maintains customer satisfaction scores that consistently exceed the technology industry average, contributing to the company being selected by trial sponsors and CROs to support more than 6,000 trials across more than 115 countries. Suvoda recently merged with Greenphire, a leading provider of clinical trial financial management and patient support tools. To learn more, visit suvoda.com and follow Suvoda on LinkedIn. Media Contact: Robin Abadía Director, External Communications, Suvoda [email protected] Report this content If you believe this article contains misleading, harmful, or spam content, please let Tamar Securities, LLC know.

Suvoda patient app earns "best Patient Relationship Management Solution" In 2026 MedTech Breakthrough Awards program. Landmark 10th annual Awards program recognizes the most innovative digital health and medical technology solutions worldwide. LOS ANGELES, May 07, 2026 (GLOBE NEWSWIRE) - MedTech Breakthrough, an independent market intelligence organization that recognizes the most innovative companies, technologies, and products in the global digital health and medical technology market, today announced that Suvoda, a global leader in clinical trial technology, has been selected as winner of the "Best Patient Relationship Management Solution" award in the 10th annual MedTech Breakthrough Awards program. The 2026 MedTech Breakthrough Award recognizes the breakthrough innovation of Suvoda's patient app, which offers a single streamlined mobile experience where patients can manage the essentials of clinical trial participation. Patients in clinical trials often have to manage ongoing financial costs, frequent clinic visits, data reporting, and logistical coordination. These demands can place additional strain on patients, particularly those managing complex or serious conditions, as well as on the clinical sites responsible for supporting them. The Suvoda App centralizes key activities and details, connecting patients and sites through a single mobile experience that simplifies participation and improves communication. For example, patients can schedule visits, complete questionnaires about their health status, view travel details and itineraries, and manage payments, including uploading receipts on their own phones or tablets, or ones provided by the study sponsor if needed. Automated reminders and notifications keep participants on top of visits, questionnaires, and key tasks, helping studies stay on track. Self-serve, in-app scheduling lets patients pick available site appointment times within their visit windows, while calendar integrations will help them fit trial visits into their everyday schedules. Patients log in with a simple, secure sign-in and can access a dashboard with assigned tasks. Additionally, with the embedded Greenphire Patient Payments, patients can submit travel receipts and receive participation stipends and reimbursements quickly in their local currency. They can choose the payment method that works best for them, including direct-to-bank, and virtual or physical debit cards. "We built this app with patients in mind. How they think, what they need, and what makes things easier in their day-to-day lives," said Jagath Wanninayake, Suvoda CEO. "When everything is in one place and works the way people expect, it removes a lot of the friction that comes with trial participation. Thank you to MedTech Breakthrough for this recognition. We plan to keep focusing on making the trial experience more manageable and more human for everyone involved." Now celebrating its 10th anniversary, the MedTech Breakthrough Awards program has spent a decade recognizing the companies driving meaningful progress and improving patient care across the global health and medical technology industry. The program spans a wide range of categories - including Telehealth, Clinical Administration, Patient Engagement, Electronic Health Records (EHR), Virtual Care, Medical Devices and beyond - honoring the innovations reshaping how care is delivered worldwide. This year's program drew a record-breaking number of nominations from leading companies and startups across more than 20 countries, reflecting the growing global impact and momentum of the digital healthcare industry. "The Suvoda app unifies the tasks that matter most to clinical trial participants into one mobile experience. Most participants juggle multiple portals, apps, and communication channels just to complete basic study tasks. Hurdles, from time commitment and logistics to expenses, can deter trial participation, with most delays due to deficient recruitment and retention," said Steve Johansson, managing director, MedTech Breakthrough. "Where many patient engagement solutions solve one step of the journey, the Suvoda app centralizes key information and steps, significantly enhancing the trial experience so participants are more likely to stay enrolled in the trial. Congratulations on winning 'Best Patient Relationship Management Solution.'" About MedTech Breakthrough Part of Tech Breakthrough, a leading market intelligence and recognition platform for global technology innovation and leadership, the MedTech Breakthrough Awards program is devoted to honoring excellence and innovation in medical & health technology companies, products, services and people. The MedTech Breakthrough Awards provide a platform for public recognition around the achievements of breakthrough healthcare and medical companies and products in categories that include Patient Experience & Engagement, Health & Fitness, Medical Devices, Clinical Administration, Connected Healthcare, Medical Data, Healthcare Cybersecurity and more. For more information visit MedTechBreakthrough.com. Tech Breakthrough LLC does not endorse any vendor, product or service depicted in its recognition programs, and does not advise technology users to select only those vendors with award designations. Tech Breakthrough LLC recognition consists of the opinions of the Tech Breakthrough LLC organization and should not be construed as statements of fact. Tech Breakthrough LLC disclaims all warranties, expressed or implied, with respect to this recognition program, including any warranties of merchantability or fitness for a particular purpose. About Suvoda Suvoda is a global clinical trial technology company with a market-leading, real-time software platform that empowers sponsors and CROs to make confident decisions and sites and patients to take calm, controlled action. Suvoda delivers interconnected, action-driven software solutions and industry-leading services and support, so that even in the most time-sensitive, mission-critical moments, life-changing studies keep moving forward. Headquartered outside Philadelphia, Suvoda also maintains offices in Portland, OR, Barcelona, Spain, Bucharest and Iasi, Romania, and Tokyo, Japan. The company maintains customer satisfaction scores that consistently exceed the technology industry average, contributing to the company being selected by trial sponsors and CROs to support more than 6000 trials across more than 115 countries. Suvoda recently merged with Greenphire, a leading provider of clinical trial financial management and patient support tools. To learn more, visit suvoda.com and follow Suvoda on LinkedIn.

Suvoda, a clinical trial technology company, has launched agentic RTSM, using AI to reduce clinical trial startup timelines by up to 80%. The system can take a study from project kickoff to User Acceptance Testing in as little as two weeks, compared to the months traditionally required. The technology employs multiple AI agents to accelerate study builds, software configuration, customisation and testing. Built on Suvoda's patented platform, it leverages virtual partition architecture and low-code tools, drawing on data from thousands of previous trials. Suvoda is currently working with early adopters to deploy the technology and plans to extend the agentic model to its eCOA and financial services products. The company also operates Sofia, an AI assistant being enhanced to support trial monitoring and alerts.